Patent Assignment
Reel/Frame 064533/0659
Assignment of Assignor's Interest
Recorded: 2023-08-09
Pages: 6
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
4995 BRADENTON AVENUE, DUBLIN, OHIO, 43017
Covered Property
(1)
Altering Net Charge on Mannosylated Dextrans to Maximize Target Tissue Uptake and Off Target Competitive Blocking
Patent:
11,833,170 →
Application:
18/164,296 →
Publication:
US 2023/0248757
PCT:
PCT/US2023/061961 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Sep 26, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 068711/0393 →
Corrective Assignment to Correct the Receiving Party Information Previously Recorded on Reel 68711 Frame 393. Assignor(S) Hereby Confirms the Security Agreement.
Sep 27, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: SCOTT, JOHN KIM, JR.
Reel/Frame 069165/0332 →
Us Bankruptcy Court Sale Order Dated Jan. 30, 2026 to Release Security Interest Recorded at 069165 / 0332
Feb 12, 2026
From: SCOTT, JOHN KIM, JR.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 074831/0644 →